ALNY slides moderately
The stock is drifting down with low volatility, roughly tracking the broader biotech sector's soft tone while the S&P 500 also slips, and the only visible news is a routine conference appearance that doesn't appear to be moving the price.
Sources: https://www.gurufocus.com/news/alnylam-pharmaceuticals-inc-at-wells-fargo-healthcare-conference-transcript
Previous verdicts for ALNY
- AI Search: Analyst Commentary and Insider Filing Weigh on Alnylam Shares — 2026-10-13
- Target cut hits ALNY — 2026-10-01
- Analyst trims target — 2026-09-30
- RNAi sector buzz lifts ALNY — 2026-09-25
- ALNY slides moderately — 2026-09-10
Sources
Ezbrisk weighs each event against the market reaction and publishes a verdict with an overreaction reading. How the methodology works